| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/05/1998 | US5747530 Aromatic dibenzofuran compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/05/1998 | US5747515 Heterocyclic compounds and compositions having nevropharmacological potential |
| 05/05/1998 | US5747514 Metalloproteinase inhibitors |
| 05/05/1998 | US5747513 Hypotensive agents, heart failure and cerebrovascular insufficiency |
| 05/05/1998 | US5747509 Prevention of occlusion in arteries |
| 05/05/1998 | US5747508 Amidinohydrazones of ketones derived from benzo B!furan, methods for their production, and pharmaceuticals containing these compounds |
| 05/05/1998 | US5747507 Myocardial disease |
| 05/05/1998 | US5747505 Heterocyclic aryl-, alkyl- and cycloalkylacetamides |
| 05/05/1998 | US5747501 Indole derivatives |
| 05/05/1998 | US5747496 Inhibitors of platelet aggregation |
| 05/05/1998 | US5747458 Plasminogen activator of protease and tripeptides |
| 05/05/1998 | US5747457 Linear adhesion inhibitors |
| 05/05/1998 | US5747451 Diagnosis and prevention of arteriosclerosis |
| 05/05/1998 | US5747319 Human mRNA editing enzyme |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747303 Intermediates of peptide antagonists of neurotensin |
| 05/05/1998 | US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
| 05/05/1998 | US5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 05/05/1998 | US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 05/05/1998 | CA2109956C Nitroglycerine plaster and process for making it |
| 04/30/1998 | WO1998017779A1 NOVEL FabH |
| 04/30/1998 | WO1998017690A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | WO1998017678A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 04/30/1998 | WO1998017672A1 Substituted aminoalkane phosphonic acids |
| 04/30/1998 | WO1998017671A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/30/1998 | WO1998017668A1 Thienopyrimidine with phosphodiesterase v inhibiting effect |
| 04/30/1998 | WO1998017652A1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 04/30/1998 | WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 04/30/1998 | WO1998017280A1 Method of treatment of heart disease caused by chlamydia pneumoniae |
| 04/30/1998 | DE19644228A1 Thienopyrimidine Thienopyrimidines |
| 04/30/1998 | CA2269656A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | CA2268876A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | CA2263732A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0838218A1 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837864A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 04/29/1998 | EP0837854A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837683A1 Preparation and use of sulfated oligosaccharides |
| 04/29/1998 | EP0837676A1 Use of pyruvate for retarding neutrophil infiltration and morphologic loss in ischemic bowel |
| 04/29/1998 | EP0734373B1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them |
| 04/29/1998 | EP0720597B1 Triaryl-ethylene derivatives for use in therapy |
| 04/29/1998 | EP0536269B1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1180351A Benzothiazine dioxides as endothelin antagonists |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744500 Administering to treat brain ischemia or stroke |
| 04/28/1998 | US5744496 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/28/1998 | US5744493 3-amidopyrazole derivatives and pharmaceutical compositions containing them |
| 04/28/1998 | US5744491 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 04/28/1998 | US5744488 Indole derivatives thromboxane A2 antagonists |
| 04/28/1998 | US5744471 Pyridazion quinoline compounds |
| 04/28/1998 | US5744467 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 04/28/1998 | US5744457 Compositions and methods for inhibiting thrombogenesis |
| 04/28/1998 | US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| 04/28/1998 | US5744362 Antisense oligonucleotide modulation of raf gene expression |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744124 Container having pump spray means for dispensing spray dosage into buccal area; propellant-free |
| 04/23/1998 | WO1998016644A1 Fibroblast growth factor homologs |
| 04/23/1998 | WO1998016643A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016525A1 SELECTIVE FACTOR Xa INHIBITORS |
| 04/23/1998 | WO1998016523A2 Selective factor xa inhibitors |
| 04/23/1998 | WO1998016521A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016512A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | WO1998016509A1 Simple process for producing high-quality captopril |
| 04/23/1998 | WO1998016507A2 New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases |
| 04/23/1998 | WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016223A1 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | DE19643037A1 Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel New oxadiazoles, processes for their preparation and their use as medicaments |
| 04/23/1998 | CA2268917A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268281A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268264A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268007A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | CA2249543A1 Simple process for producing high-quality captopril |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837055A1 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836610A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 04/22/1998 | EP0836599A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 04/22/1998 | EP0836597A1 N-substituted piperazine nonoates |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0644891B1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/22/1998 | EP0618906B1 Substituted imidazole derivatives and their preparation and use |